Method of administering a hormone encapsulated by a hydrogel with a dual chamber syringe
AssigneeVitalte Lifesciences Inc.
InventorsCharles P. Virden, Stephen Harrington, Stella Vnook
Life of this patent
Estimating the term…
Loading patent…
AssigneeVitalte Lifesciences Inc.
InventorsCharles P. Virden, Stephen Harrington, Stella Vnook
Estimating the term…
A method for administering a hormone encapsulated by a hydrogel polymer with a dual chamber syringe is described. The method includes providing a crosslinked methacrylate hyaluronic acid (MHA) polymer that encapsulates a hormone. The crosslinked MHA polymer is the hydrogel polymer. A dosage of the crosslinked MHA polymer that encapsulates the hormone to a subcutaneous tissue is administered with a dual chamber syringe. The dual chamber syringe includes a first chamber, a second chamber, a separator, and a plunger. The first chamber includes the crosslinked MHA polymer that encapsulates the hormone. The second chamber has a diluent for the crosslinked MHA polymer. The separator separates the first chamber from the second chamber. Piercing or bypassing the separator generates a mixture that includes the diluent and the crosslinked MHA polymer that encapsulates the hormone. The plunger forces the mixture through a needle.
A method for administering a hormone encapsulated by a hydrogel polymer with a dual chamber syringe, the method comprising:
A method for administering a hormone encapsulated by a hydrogel polymer with a dual chamber syringe, the method comprising:
Dependencies are inferred from the claim text.